Kulkarni Samarth bought CRSP
October 26, 2026 · Form 4 insider transaction
Kulkarni Samarth bought 28,750 shares of CRISPR Therapeutics AG at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
28,750
Price
$0.00
Total value
N/A
InsiderKulkarni Samarth
RoleOfficer, Director
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateOctober 26, 2026
Filing dateOctober 28, 2026
Shares owned after28,750
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.; This restricted stock unit award was granted on October 26, 2026 with respect to 28,750 Common Shares, with (i) one quarter of the shares vesting on October 26, 2027, (ii) one quarter of the shares vesting on October 26, 2028, (iii) one quarter of the shares vesting on October 26, 2029, and (iv) one quarter of the shares vesting on October 26, 2030.